In addition, alterations in the RHO/RAC signalling pathway are frequently associated with IBD-CRC with exome sequencing studies suggesting a prevalence of 50–70% of tumours having alterations in this pathway [6, 7]. The gene discussed is AKT1; the disease is inflammatory bowel disease.